UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Planning for retirement in your 30s requires understanding key insights. Equip yourself with knowledge to secure a prosperous future.
18,862 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Oil breaks $100 again as Middle East tensions flare, lifting energy stocks and reshaping risk-on bets for 2026. Inves...
Casey’s General Stores posted stronger fuel margins and a growing Rewards base, lifting investor optimism. Analysts c...
ServiceNow's stock is down this year, but CEO Bill McDermott argues AI will accelerate growth, not derail it, outlini...
Whales keep piling into Bitcoin as volatility persists. A rising number of 100+ BTC wallets points to sustained inter...
Crypto assets extended a broad sell-off as ETF withdrawals surged and traders priced in heightened risk. Prices retre...
Better Home & Finance and Coinbase unveil the first Fannie Mae-backed mortgage using bitcoin as collateral, signaling...
An obscure AI-focused ETF has outperformed the Nasdaq by concentrating on hard-to-access AI players in Korea and Taiw...
Daily RSI divergence is signaling momentum fatigue for ETH, even as prices hover near key supports. This ethereum pri...
A new Morgan Stanley note argues Rocket Lab’s shift into satellite data and services could unlock substantial upside,...
Non-China emerging markets have moved to the forefront of global returns in 2026, delivering double-digit gains even ...
Apple’s 2026 strategy centers on Services and cash returns, contrasting with Amazon’s AI infrastructure push, shaping...